ABBV 8-K 2026-10-05

AbbVie Inc. (ABBV) 8-K dated 2026-10-05 — accession 0001551152-26-000030. This URL is the filing, not the ABBV hub.

AbbVie Inc. (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.

ABBV: SECURITIES AND EXCHANGE COMMISSION

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 110.2.

Not investment advice. The ABBV SEC hub lists recent forms. The stock page is the research view.